TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Oleanolic Acid, Gemcitabine
Phytochemical Name Oleanolic Acid (PubChem CID: 10494 )
Anticancer drug Name Gemcitabine (PubChem CID: 60750 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 193
Pair Name Oleanolic Acid, Gemcitabine
Disease Info [ICD-11: 2C10] Pancreatic cancer Investigative
Biological Phenomena Induction-->Mitochondrial damage
Gene Regulation Down-regulation Expression EGFR hsa1956
Down-regulation Expression EZH2 hsa2146
Down-regulation Expression MAP2K7 hsa5609
Down-regulation Expression MAPK1 hsa5594
Down-regulation Expression SPINK1 hsa6690
In Vitro Model AsPC-1 Pancreatic ductal adenocarcinoma Homo sapiens (Human) CVCL_0152
MIA PaCa-2 Pancreatic ductal adenocarcinoma Homo sapiens (Human) CVCL_0428
Result We found an interesting finding that the 73-03 in combination with GCB can improve GCB efficacy and decrease PCa resistance, which induced apoptosis and mitochondrial damage through epigenetic inhibition of SPINK1 transcription by miR-421 up-regulation. This was the first study that used OA derivatives on GCB-resistant PCa cells, so this combined strategy warrants further investigation.
03. Reference
No. Title Href
1 Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells. Phytomedicine. 2021 Oct;91:153711. doi: 10.1016/j.phymed.2021.153711. Click
It has been 47416 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP